BOLT vs IDXX · rev $31.0K vs P/E 40, rev $2.36B
Bolt Biotherapeutics (BOLT) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported BOLT revenue for 2026-06-30 was $31.0K. Net income was -$15.0M. Revenue was up 19.2% from 2026-03-31 to 2026-06-30. BOLT currently screens at market cap $11.3M.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
BOLT currently screens at market cap $11.3M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the BOLT and IDXX stock pages for the full models.
Not investment advice.